Business Segments Haemonetics Corporation

Stocks

Market Closed - NYSE 16:04:45 2026-09-18 EDT			5-day change	1st Jan Change
108.40 ^USD	+0.74%		+5.56%	+35.25%

09-17	Haemonetics Shares Rise After Citigroup Upgrade	MT
09-17	Citigroup Upgrades Haemonetics to Buy From Neutral, Adjusts Price Target to $123 From $92	MT

Breakdown by Business Segment (USD)

Fiscal Period: March	2022	2023	2024	2025	2026
Medical Consumables
MedSurg	322M	378M	446M	564M	588M
D&A	36.94M	37.77M	38.11M	57.24M	57.19M
Operating Income	130M	154M	184M	88.98M	104M
All Other	-	-	-	-	-
Total Assets	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
	-	-	-	-	588M
Japan	-	-	-	-	-
Total Assets	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Healthcare Industry Software
Plasma	352M	500M	565M	535M	524M
D&A	28.31M	41.61M	45.71M	48.26M	47.37M
Operating Income	183M	279M	310M	185M	185M
North America Plasma	-	-	-	-	-
Total Assets	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
	-	-	-	-	524M
Medical Testing, Analyzing, and Diagnostic Equipment
Blood Center	295M	289M	279M	261M	221M
D&A	32.49M	13.93M	13.39M	10.08M	7.16M
Operating Income	137M	132M	110M	52.82M	49.98M
Europe, Middle East and Africa (EMEA)	-	-	-	-	-
Total Assets	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
	-	-	-	-	221M
Unallocated Service	20.81M	21.42M	21.63M	-	-
Unallocated Effect of Exchange Rates	4.32M	-20.82M	-2.92M	-	-
Operating Income	18.99M	8.42M	-1.97M	-	-
Operating Income	-281M	-355M	-325M	-	-

Geographical breakdown of sales (USD)

Fiscal Period: March	2022	2023	2024	2025	2026
United States	639M	843M	970M	1.01B	982M
Total Assets	201M	252M	246M	217M	225M
Europe	164M	157M	160M	176M	185M
Total Assets	11.99M	14.59M	15.31M	20.02M	32.08M
	-	-	-	-	68.2M
Rest of Asia	111M	104M	108M	92.3M	87.21M
Total Assets	28.13M	26.26M	26.73M	28.7M	30.83M
	-	-	-	-	185M
Japan	75.56M	61.3M	58.09M	62.41M	68.2M
Total Assets	1.1M	997K	1.6M	1.25M	916K
	-	-	-	-	982M
Other	3.99M	3.65M	13.28M	19.54M	11.42M
Total Assets	16.34M	17.23M	21.25M	16.86M	17.23M
	-	-	-	-	87.21M
	-	-	-	-	11.42M